FindTrial
Sign In

Ama evaluation in Rheumatoid arthritis(Amavata)with reference to RA-Factor and CRP.

ANALYTICAL STUDY OF AMA IN RELATION TO RHEUMATOID FACTOR AND CRP IN RHEUMATOID ARTHRITIS(AMAVATA) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/074910
Enrollment
35
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M049- Autoinflammatory syndrome, unspecified

Interventions

None listed

Sponsors

Rishikul CampusUAU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling ACR/EULAR criteria 2020.

Exclusion criteria

Exclusion criteria: 1-Pregnant women and lactating mother. 2-Individual having cardiovascular disease, abnormal thyroid hormone, renal disease , HIV, Viral hepatitis, carcinoma, SLE, Leprosy and other auto-immune diseases

Design outcomes

Primary

MeasureTime frame
Assessment of Ama in rheumatoid arthritis(Amavata)with the level of CRP.Timepoint: 01 month—

Secondary

MeasureTime frame
Assessment of Ama in rheumatoid arthritis(Amavata)with the level RA Factor.Timepoint: 01 month—

Countries

India

Contacts

Public ContactDr Ruby Rani Agarwal

Rihikul Ayurvedic College,Haridwar

ruby6758@gmail.com9456100745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026